Webinar

Biospecimens & Multi-Omics in Clinically Relevant Research

June 25, 2025 -11:00 AM ET, 04:00 PM CET

High-quality biospecimens and cutting-edge multi-omics tools are transforming clinical research. Join our experts for an insightful 30-minute session to see how your research can benefit from our biospecimen offering—designed for real-world needs with rapid ischemia control, standardized protocols, and rigorous quality standards.

We’ll dive into our multi-omics capabilities, showing how spatial transcriptomics combined with multiplex IHC creates a powerful platform for biomarker discovery. We’ll also explore our multi-omics toolkit, which combines fluorescent multiplex IHC with 10x Genomics’ Visium Spatial Transcriptomics to enable simultaneous visualization of gene and protein expression.

This integrated approach reveals both validated targets (like p53-pathway genes) and novel biomarkers relevant to colorectal cancer and beyond. You’ll also understand the clinical impacts from case studies and real-world applications, helping you to progress your research.

Attend this webinar to learn how to:

• Enhance translational research with access to rigorously collected, high-integrity biospecimens, including longitudinal plasma, with proven quality metrics and minimized preanalytical variability.
  
  
• Accelerate biomarker discovery through a validated multi-omics workflow combining spatial transcriptomics and multiplex IHC, enabling simultaneous analysis of gene and protein expression within histological context.
  
  
• Inform study design and future protocols by understanding how customizable biospecimen strategies and spatial multi-omics can support diverse study types, from early exploratory phases to late-stage clinical validation.

Save Your Seat Now

Meet Our Presenters:

Katharina Krohn, Senior Director, Global Biobanks, Crown Bioscience

Katharina Krohn leads Crown Bioscience’s Surgical Biobanking business including all global operations from the various clinical networks. Before joining the company, she was employed at the Center for Biochemistry and Molecular Cell Biology at the University Medical Center in Göttingen. Her work focused on molecular biology and protein biochemistry and protein biochemical experiments on the expression and purification of recombinant proteins. Katharina started within the pathology department as a technician in 2014, responsible for the coordination and execution of customer projects. Her first activities as a biobank manager began in 2016 resulting in the founding of today's Liquid Biopsy Biobank.

Snehal Padhye PhD MBA, Director, Scientific Engagement, Crown Bioscience

Dr. Snehal Padhye is the Director of Business Development at Crown Bioscience, a JSR Life Sciences company. With a Ph.D. in Cancer Biology and an MBA, Dr. Padhye brings an impactful combination of deep scientific expertise and strategic business acumen to the preclinical oncology space. She is instrumental in helping Crown Bioscience's partners de-risk and accelerate their therapeutic development. Dr. Padhye's unique perspective is invaluable for researchers navigating the complexities of cancer biology and the journey from drug discovery to clinical impact.